NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Jun. 21, 2018--
Lantheus
Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus
Medical Imaging, Inc. (“LMI”), a global leader in the development,
manufacture and commercialization of innovative diagnostic imaging
agents and products, today announced that Mary Anne Heino, President and
Chief Executive Officer, and Jack Crowley, Chief Financial Officer, will
present at the CJS Securities 18th Annual “New Ideas” Summer
Conference on Tuesday, July 10, 2018, in White Plains, NY.
A copy of the presentation will be available on the Investors
section of the Company’s website at www.lantheus.com.
About Lantheus Holdings, Inc. and Lantheus Medical Imaging, Inc.
Lantheus
Holdings, Inc. is the parent company of LMI, a global leader in the
development, manufacture and commercialization of innovative diagnostic
imaging agents and products. LMI provides a broad portfolio of products,
including the echocardiography contrast agent DEFINITY® Vial
for (Perflutren Lipid Microsphere) Injectable Suspension; TechneLite®
(Technetium Tc99m Generator), a technetium-based generator that provides
the essential medical isotope used in nuclear medicine procedures; and
Xenon (Xenon Xe 133 Gas), an inhaled radiopharmaceutical imaging agent
used to evaluate pulmonary function and for imaging the lungs. The
Company is headquartered in North Billerica, Massachusetts with offices
in Puerto Rico and Canada. For more information, visit www.lantheus.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180621005984/en/
Source: Lantheus Holdings, Inc.
Lantheus Holdings, Inc.
Meara Murphy, 978-671-8508
Director,
Investor Relations & Corporate Communications
